Compare STVN & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STVN | IRTC |
|---|---|---|
| Founded | 1949 | 2006 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.8B |
| IPO Year | 2021 | 2016 |
| Metric | STVN | IRTC |
|---|---|---|
| Price | $15.48 | $116.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $25.67 | ★ $207.54 |
| AVG Volume (30 Days) | 524.4K | ★ 625.6K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 0.40% | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $747,138,000.00 |
| Revenue This Year | $10.26 | $19.58 |
| Revenue Next Year | $10.02 | $15.95 |
| P/E Ratio | $27.15 | ★ N/A |
| Revenue Growth | N/A | ★ 26.24 |
| 52 Week Low | $13.91 | $92.52 |
| 52 Week High | $28.00 | $210.01 |
| Indicator | STVN | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 31.01 |
| Support Level | $14.03 | N/A |
| Resistance Level | $17.14 | $161.36 |
| Average True Range (ATR) | 0.83 | 5.55 |
| MACD | 0.08 | -0.66 |
| Stochastic Oscillator | 38.75 | 15.08 |
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.